Abstract:Chronic systemic immune activation significantly influences human immunodeficiency virus (HIV) disease progression. Despite evidence of a pro-inflammatory environment in the genital tract of HIV-infected women, comprehensive investigations into cervical tissue from this region remain limited. Similarly, the consequences of chronic HIV infection on the integrity of the female genital epithelium are poorly understood, despite its importance in HIV transmission and replication. Ectocervical biopsies were obtained from HIV-seropositive (n = 14) and HIV-seronegative (n = 47) female Kenyan sex workers. RNA sequencing and bioimage analysis of epithelial junction proteins (E-cadherin, desmoglein-1, claudin-1, and zonula occludens-1) were conducted, along with CD4 staining. RNA sequencing revealed upregulation of immunoregulatory genes in HIV-seropositive women, primarily associated with heightened T cell activity and interferon signaling, which further correlated with plasma viral load. Transcription factor analysis confirmed the upregulation of pro-inflammatory transcription factors, such as RELA , NFKB1 , and IKZF3 , which facilitates HIV persistence in T cells. Conversely, genes and pathways associated with epithelial barrier function and structure were downregulated in the context of HIV. Digital bioimage analysis corroborated these findings, revealing significant disruption of various epithelial junction proteins in ectocervical tissues of the HIV-seropositive women. Thus, chronic HIV infection associated with ectocervical inflammation, characterized by induced T cell responses and interferon signaling, coupled with epithelial disruption. These alterations may influence HIV transmission and heighten susceptibility to other sexually transmitted infections. These findings prompt exploration of therapeutic interventions to address HIV-related complications and mitigate the risk of sexually transmitted infection transmission. Chronic immune activation is a key feature of human immunodeficiency virus (HIV) infection and is linked to various health issues, including sexually transmitted infections. The consequence of immune activation is becoming evident as age-related morbidities are appearing in younger people living with HIV. The female genital tract is a primary location for initial HIV infection and replication following sexual transmission. While we know that chronic HIV infection causes inflammation in the tissue, more detailed studies, especially focusing on mucosal epithelial tissue, are still needed. To understand how chronic HIV infection affects the female genital tract, we examined samples from HIV-positive and HIV-negative Kenyan female sex workers. We found that chronic HIV infection is associated with a sustained cervical inflammatory environment. We also noticed a decrease in genes responsible for maintaining the protective epithelial barrier in the tissue. Our results suggest a connection between HIV-induced immune responses in mucosal areas and the health of the tissue, which might explain why HIV infection may increase the risk of other sexually transmitted infections. This highlights the importance of enhancing mucosal health in people living with chronic HIV to reduce associated complications.

The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women

Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients

Mechanisms of sexually transmitted infection-induced inflammation in women: implications for HIV risk

Protective Effect of Probiotic Bacteria and Estrogen in Preventing HIV-1-Mediated Impairment of Epithelial Barrier Integrity in Female Genital Tract

Sex Hormones, the Stool Microbiome, and Subclinical Atherosclerosis in Women with and Without HIV.

Sustained immune activation and impaired epithelial barrier integrity in the ectocervix of women with chronic HIV infection

Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome

Anatomic and Hormonal Changes in the Female Reproductive Tract Immune Environment during the Life Cycle: Implications for HIV/STI Prevention Research

Vaginal Bacteria and Proinflammatory Host Immune Mediators as Biomarkers of Human Immunodeficiency Virus Acquisition Risk Among African Women

Prevotella timonensis bacteria associated with vaginal dysbiosis enhance HIV-1 susceptibility of vaginal CD4+ T cells

Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age

Effect of progestin-based contraceptives on HIV-associated vaginal immune biomarkers and microbiome in adolescent girls

Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in Malawi

Determinants of Vaginal Microbiota Composition

Proinflammatory oscillations over the menstrual cycle drives bystander CD4 T cell recruitment and SHIV susceptibility from vaginal challenge

Mucosal Susceptibility to Human Immunodeficiency Virus Infection in the Proliferative and Secretory Phases of the Menstrual Cycle

Immune activation and inflammation in lactating women on combination antiretroviral therapy: role of gut dysfunction and gut microbiota imbalance

The impact of pregnancy on anti-HIV activity of cervicovaginal secretions

Menopause and Estrogen Associations With Gut Barrier, Microbial Translocation, and Immune Activation Biomarkers in Women With and Without HIV

Bacterial vaginosis-driven changes in vaginal T cell phenotypes and their implications for HIV susceptibility

Low genitourinary tract risks in women living with the human immunodeficiency virus